Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 16.350\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any additional words.
Options:
(a) O=C(OCC1CC(c2ccccc2)=NO1)c1ccc(Br)cc1
(b) FC(F)(F)C1=CC(c2ccc(Cl)cc2)=NCCN1
(c) CCNC(=S)NCc1ccc2c(c1)OCO2
(d) C/C(=C\c1ccccc1)C1Nc2cccc3cccc(c23)N1
(e) CCCC(=O)Nc1nnc(S(=O)(=O)N2CCCC2)s1
Answer: e. CCCC(=O)Nc1nnc(S(=O)(=O)N2CCCC2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCC(=O)Nc1nnc(S(=O)(=O)N2CCCC2)s1
CCCC(=O)Nc1nnc(S(=O)(=O)N2CCCC2)s1
N-(5-pyrrolidin-1-ylsulfonyl-1,3,4-thiadiazol-2-yl)butanamide